Trademark: 78891327
Word
INSPIRECF
Status Date
Tuesday, April 7, 2009
Filing Date
Wednesday, May 24, 2006
Published for Opposition
Tuesday, November 6, 2007
Abandoned Date
Wednesday, March 4, 2009
5 Pharmaceutical compositions for the treatment of cystic fibrosis, namely, pharmaceutical compositions containing denufosol tetrasodium
Color is not claimed as a feature of the mark.
The mark consists of a tiger head with the word inspirecf positioned above it.
Apr 7, 2009
Abandonment Notice Mailed - Failure To Respond
Apr 7, 2009
Abandonment - Failure To Respond Or Late Response
Sep 3, 2008
Non-Final Action Mailed
Sep 3, 2008
Su - Non-Final Action - Written
Aug 8, 2008
Statement Of Use Processing Complete
Jul 28, 2008
Use Amendment Filed
Aug 8, 2008
Case Assigned To Intent To Use Paralegal
Jul 28, 2008
Teas Statement Of Use Received
Jan 29, 2008
Noa Mailed - Sou Required From Applicant
Nov 6, 2007
Published For Opposition
Oct 17, 2007
Notice Of Publication
Oct 2, 2007
Law Office Publication Review Completed
Oct 2, 2007
Approved For Pub - Principal Register
Sep 26, 2007
Teas/Email Correspondence Entered
Sep 26, 2007
Correspondence Received In Law Office
Sep 25, 2007
Teas Request For Reconsideration Received
May 30, 2007
Final Refusal Mailed
May 29, 2007
Final Refusal Written
May 23, 2007
Assigned To Examiner
May 9, 2007
Teas/Email Correspondence Entered
May 9, 2007
Correspondence Received In Law Office
May 9, 2007
Assigned To Lie
Apr 16, 2007
Teas Response To Office Action Received
Oct 27, 2006
Non-Final Action Mailed
Oct 26, 2006
Non-Final Action Written
Oct 25, 2006
Assigned To Examiner
Jun 1, 2006
Notice Of Design Search Code Mailed
May 31, 2006
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
